Mylan submits concessions to win EU approval for Abbott deal
Mylan has offered to revise its plan to buy a generic-drug business from Abbott Laboratories in order to secure EU approval for the deal. The concessions are minor, MLex has learned....To view the full article, register now.
Already a subscriber? Click here to view full article